A number of research studies have shown that stem cells taken from umbilical cord blood have several advantages over marrow and circulatory blood derived genes. Bone marrow still leads ahead of umbilical cord blood for some procedures and diseases, but it is widely believed in the medical community that the trend will sway in favor of cord blood even more in the near future.

The future of this new type of treatment is exciting, despite its current minority status in the world of transfusions. Scientists are almost certain that an person´s own cord blood will, at some point, be effective in the treatment of their own cancers. This is because the majority of adult cancers simply aren’t genetically derived, whereas pediatric cancers invariably are.

Medical researchers are hard at work finding ways of manipulating the leukemia gene, so that eventually even your own blood may be used to cure yourself, thus making cord blood even more valuable as an insurance against future ailments and disease.